GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 29.15
+0.35 (1.22%)
Sep 30, 2026, 1:08 PM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.19 billion as of September 29, 2026. Its market cap has decreased by -51.43% in one year.
Market Cap
1.19B
Enterprise Value
1.22B
Revenue
664.94M
Ranking
n/a
PE Ratio
70.19
Stock Price
29.15
ChartMarket Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.19B, a decrease of -45.08%. That is a compound annual growth rate of -5.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.22B | -38.86% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 2.17B |
| Johnson Chemical Pharmaceutical Works | 2.15B |
| TSH Biopharm Corporation | 1.94B |
| InnoPharmax | 1.24B |
| Excelsior Biopharma | 1.09B |
| Prince Pharmaceutical | 1.07B |
| Anxo Pharmaceutical | 1.01B |
| DV Biomed | 989.79M |